Format

Send to

Choose Destination
See comment in PubMed Commons below
Clin Vaccine Immunol. 2009 Aug;16(8):1105-12. doi: 10.1128/CVI.00109-09. Epub 2009 Jun 17.

Statistical approach to estimate vaccinia-specific neutralizing antibody titers using a high-throughput assay.

Author information

1
Mayo Vaccine Research Group, Mayo Clinic, Guggenheim 611C, Rochester, MN 55905, USA.

Abstract

Because of the bioterrorism threat posed by agents such as variola virus, considerable time, resources, and effort have been devoted to biodefense preparation. One avenue of this research has been the development of rapid, sensitive, high-throughput assays to validate immune responses to poxviruses. Here we describe the adaptation of a beta-galactosidase reporter-based vaccinia virus neutralization assay to large-scale use in a study that included over 1,000 subjects. We also describe the statistical methods involved in analyzing the large quantity of data generated. The assay and its associated methods should prove useful tools in monitoring immune responses to next-generation smallpox vaccines, studying poxvirus immunity, and evaluating therapeutic agents such as vaccinia virus immune globulin.

PMID:
19535540
PMCID:
PMC2725542
DOI:
10.1128/CVI.00109-09
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire Icon for PubMed Central
    Loading ...
    Support Center